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Abstract
The loss of specific neuronal phenotypes, as determined by immunohistochemistry, has
become a powerful tool for identifying the nature and cause of neurological diseases. Here
we show that the number of neurons identified and quantified using this method misses a
substantial percentage of extant neurons in a phenotype specific manner. In mice, 24%
more hypocretin/orexin (Hcrt) neurons are seen in the night compared to the day, and an
additional 17% are seen after inhibiting microtubule polymerization with colchicine. We see
no such difference between the number of MCH (melanin concentrating hormone) neurons
in dark, light or colchicine conditions, despite MCH and Hcrt both being hypothalamic pep-
tide transmitters. Although the size of Hcrt neurons did not differ between light and dark,
the size of MCH neurons was increased by 15% in the light phase. The number of neurons
containing histidine decarboxylase (HDC), the histamine synthesizing enzyme, was 34%
greater in the dark than in the light, but, like Hcrt, cell size did not differ. We did not find a sig-
nificant difference in the number or the size of neurons expressing choline acetyltransferase
(ChAT), the acetylcholine synthesizing enzyme, in the horizontal diagonal band (HBD) dur-
ing the dark and light conditions. As expected, colchicine treatment did not increase the
number of these neurons. Understanding the function and dynamics of transmitter produc-
tion within “non-visible” phenotypically defined cells has fundamental implications for our
understanding of brain plasticity.
Introduction
In mammals, waking and sleep states are generated and stabilized by the coordinated activity
of different neuronal groups. Amongst them, hypocretin (Hcrt), histamine and acetylcholine
producing neurons promote arousal whereas melanin concentrating hormone (MCH) neu-
rons promote sleep. Consistent with their role in modulating each state, Hcrt, histamine and
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cholinergic neurons show the highest levels of activity during the active phase [1] [2] [3] [4]
[5] [6] [7] whereas peak MCH release and unit activity has been reported to be prior to and
during the inactive phase [8] [9] [10] [11]. In spite of the extensive evidence indicating circa-
dian modulation of these systems, studies have so far assumed that the number of detectable
neurons in each neurochemical group remains constant across the different behavioral states.
Furthermore fluctuations in neuronal numbers have been generally associated with aging,
pathological conditions, genetic manipulation, or specific experimental procedures. For exam-
ple, in humans lesions to the posterior hypothalamus, where histaminergic neurons reside,
generate hypersomniac phenotypes [12], whereas loss of hypocretin neurons results in narco-
lepsy [13] a sleep pathology characterized by excessive daytime sleepiness, as well as intermit-
tent and uncontrollable episodes of falling asleep. Recent work showed that human narcolepsy
was accompanied by an increase in the number of histamine cells [14] [15]. Loss of histamine
in animals results in an inability to maintain waking in novel environments and slowing of the
EEG in spite of normal amounts of sleep and wake [12], whereas loss of Hcrt cells produces
narcoleptic phenotypes. Genetically modified animals can also express altered number of neu-
rons compared to wild type controls. For example, narcoleptic dogs lacking the hypocretin
receptor 2 have a higher number of cholinergic neurons in the pedunculopontine nuclei
[16] [17], whereas the genetic rat model Flinders Sensitive Line displays a higher number of
Hcrt neurons [18]. Castration of male mice [19] or lipopolysaccharide administration [20]
decrease the number of Hcrt expressing neurons whereas an agonist of the estrogen receptor α
decreases the number of MCH expressing neurons [21] and parasitic infection with Trypano-
soma brucei reduces both Hcrt and MCH cell numbers [22], indicating that the cell number of
these hypothalamic populations may be modulated in response to an environmental challenge.
Because of the circadian modulation of these systems and the evidence indicating that neu-
ronal numbers can fluctuate in response to different challenges we sought to determine if there
is a physiological variation in the number of neurons that express Hcrt, histamine and MCH.
Materials and methods
Subjects
Sixteen-week-old male mice (C57BL/6J) from Charles River Laboratories were used. Animals
were kept in a room maintained at 22±1˚C on a 12 h light (45 lux) dark (0.03 lux) cycle (lights
on 7 AM and off 7 PM). All procedures were approved by the Institutional Animal Care and
Use Committee of the University of California at Los Angeles and of the Veterans Administra-
tion Greater Los Angeles Health Care System.
Light/Dark phase
Naïve mice (n = 16) were maintained undisturbed in their home cage in an isolated room,
except for a weekly bedding change and food/water replenishment to ensure ad libitum feeding
conditions. Starting seven days before sacrifice, the animals where kept completely undis-
turbed. In this experimental group the subjects were sacrificed at ZT 5 (5 hours after light
onset) and at ZT 17 (5 hours after light offset).
Colchicine administration
Twenty-six animals were subjected to intracerebroventricular (ICV) injection of either saline
solution (n = 13) or saline solution containing 20 μg/μl of colchicine (n = 13). Anesthesia was
induced with a mixture of ketamine/xylazine (100 mg/kg/15 mg/kg, i.p.) and then maintained
with a gas mixture of isoflurane in oxygen (0.6–1.2%) after the animals were placed in the
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stereotaxic device. Body temperature was maintained with a water-circulated heating pad
(Gaymar Industries, Orchard Park, NY, USA). The head was positioned in a stereotaxic frame
and the skull was exposed. A single hole was drilled at coordinates corresponding to the lateral
ventricle (AP: -0.5 mm, L: -1 mm, relative to bregma). A Hamilton microsyringe was lowered
until the ventricle was reached (H: -2.8 mm, relative to the skull surface). Infusion was made in
increments of 0.2 μl every 10 minutes for 40 minutes to obtain a final volume of 1 μl. The nee-
dle was held in place for another 10 minutes before slowly withdrawing it. Ventricular localiza-
tion was confirmed by observing free flowing cerebrospinal fluid after the withdrawal of the
needle. A small piece of sterile bone wax was placed over the hole and the skin sutured. All
subjects recovered from the anesthesia within 30 minutes after the end of the procedure. All
animals were carefully monitored and sacrificed 52 h later between ZT 13 and ZT 15 for
immunohistochemical procedures and mRNA quantification.
Tissue processing
For tissue collection, all animals were deeply anesthetized with pentobarbital (Nembutal, 100
mg/kg, i.p.) and transcardially perfused with 0.035 l of heparinized (1000 units/l) phosphate
buffered saline (PBS, 0.1M, pH 7.4) followed by 0.07 l of 4% paraformaldehyde in phosphate
buffer (PB, 0.1M, pH 7.4). The brain was removed and coded. All subsequent procedures were
performed by an investigator blind to the procedures performed prior to sacrifice. The brain
was immersed in PBS with 20% sucrose and then transferred to 30% sucrose solution for
cryoprotection.
Forty-eight hours later, the brain was frozen and cut into 40 μm coronal sections using a
sliding microtome (American Optical, US). Each section was placed in one well of a 3-well
tray containing PBS, and immunohistochemical procedures were performed immediately. The
injection site was further confirmed by visual assessment of the specimen during the section-
ing procedure. The remaining tissue was transferred to a cryoprotectant solution and stored at
-20˚C. For Hcrt quantification during the dark/light condition, all hypothalamic sections from
all three wells were combined prior to staining.
Immunohistochemistry
All immunohistochemical procedures were performed by sequential incubation of free-float-
ing sections. The sections were first incubated in primary antibody for 72 h at 4˚C in PBS with
0.25% Triton X-100 (PBST), followed by incubation in the corresponding biotinylated second-
ary antibody in PBST (Jackson ImmunoResearch, West Grove, PA, USA), standard ABC
(Vector Laboratories, Burlingame, CA, USA) and developed with the diaminobenzidine tetra-
hydrochloride (DAB) method, which consisted of tissue immersion in 0.02% DAB and 0.03%
hydrogen peroxide in 10 ml PBS. A common practice in histology laboratories that use the
DAB method to develop immunohistochemical procedures, is to periodically examine the tis-
sue sections “under the microscope” during the developing process and remove the sections
from the DAB solution once neurons are visualized. However, this approach can add variabil-
ity to the end result. Therefore, we previously standardized our DAB method and established
an 8-minute optimal developing time and used this precise duration in all of our studies. Fur-
thermore all developing solutions were prepared in one container, homogenized and aliquoted
in the respective developing wells. All developing procedures were performed with room lights
off and the wells containing tissue were additionally wrapped with aluminum foil to protect
them from light exposure. Wells were agitated at 55 rpm and all developing solutions were
used only once. All procedures were done on coded tissue so that the individual doing the
staining and counting did not know the condition of the animals
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The following antibodies were used for peptide detection: for Hcrt-1, rabbit anti-Hcrt-1
(H-003-36, Phoenix Pharmaceuticals, USA, 1:2000, Lot # 01108), for MCH, rabbit anti-MCH
(H-070-47, Phoenix Pharmaceuticals, USA, 1:20,000, Lot # 01629–3). Identification of hista-
mine and cholinergic neurons was performed by detection of phenotypically specific enzymes
histidine decarboxylase (HDC) and choline acetyltransferase (ChAT) using rabbit anti-HDC
(EUD 2601, Acris Antibodies, Germany, 1:3000, Lot # ON 2090) or goat anti-ChAT (AB144P,
Millipore, USA, 1:2000, Lot # 2464504). All tissue sections from experimental and control ani-
mals were stained at the same time and with the same antibody lot.
Quantification of mRNA; tissue punching, RNA preparation, cDNA
synthesis and qPCR
Snap frozen brain samples from mice (8 colchicine, 8 saline) were cut into 200 μm coronal sec-
tions using a cryostat (Cryocut 1800, Reichert-Jung, Wien, Austria). All sections correspond-
ing to the tuberal and posterior hypothalamic regions (Paxinos G., 2001) were bilaterally
sampled with a 1.0 mm punching needle (Miltex, Inc. York, PA, USA). Each assay tube con-
tained pooled samples from two animals. Brain tissue was homogenized in the presence of
QIAzol Lysis Reagent (1000 μl, Qiagne Sciences. Maryland, USA) and chloroform (200 μl,
Fisher Scientific. Pittsburgh, PA USA). Isolation of RNA was performed according to the
RNeasy Lipid Tissue Mini Kit manufacturer’s protocol (Qiagne Sciences. Maryland, USA)
with the addition of RNase-Free DNase kit (Qiagne Sciences. Maryland, USA) to clear poten-
tial DNase contamination. The quality and concentration of the RNA was determined with an
Eppendorf Bio Spectrometer (Eppendorf. Hauppauge NY, USA). cDNA reactions were con-
ducted immediately, using an iScript cDNA synthesis Kit (Bio-RAD Lab. Inc. Hercules. CA,
USA). The Quantitative PCR (qPCR) procedures were performed as previously described [23]
[24]. Briefly, the Power SYBR Green PCR kit (20 μl, Life technologies, Warrington UK) with a
mixture of sense and antisense primers (2 pmol/μl) was used. GenBank accession number and
efficiency for each primer pair are provided in Table 1. Assays were run in a thermocycler (Ste-
pOnePlus real-time PCR, Applied Biosystems Grand Island, NY, USA) under the following
conditions: 2 min at 50˚C and 10 min at 95˚C, followed by 40 cycles of 15 s at 95˚C and finally
1 min at 60˚C. All qPCR assays were conducted in triplicate. Data was acquired and processed
automatically using the Applied Biosystems Sequence Detection Software. Specificity of ampli-
fication was confirmed by the melting curve and electrophoresis of products on 1.5% Agarose
gel. In addition, sterile water (non-template control) and omission of reverse transcriptase
(non-RT control) during cDNA synthesis served as negative controls. Amplification efficiency
was determined by running qPCR reactions on a dilution series of pooled cDNA from all sub-
jects. The relative expression of the genes of interest was calculated using the corresponding
Ct (threshold cycle) values. Samples were normalized to the reference gene Glyceraldehyde-
3-Phosphate Dehydrogenase (GAPDH) that is stable between the two groups [25]. The relative
Table 1. Primers used for qPCR analysis.
Gene Accession code Forward primer Reverse primer Product length (bp)
GAPDH NM_008084 GGTGGTGAAGCAGGCATCT GAAGGTGGAAGAGTGGGAGTT 106
PPHcrt NM_010410 AACCCATCTTCTATCCTTGTC CGTCTTTATTGCCATTTACC 83
PPMCH NM_029971.2 GAACACAGGCTCCAAACA GCATTCTGAACTCCATTCTC 120
Abbreviations: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PPHcrt, prepro hypocretin/orexin; PPMCH, prepro melanin concentrating hormone
https://doi.org/10.1371/journal.pone.0178573.t001
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amount of target gene in relation to the reference gene was calculated using the 2^(-delta delta
Ct) method as described by Livak and Schmittgen (ibid).
Data collection
The number and distribution of Hcrt, HDC, ChAT and MCH cells was assessed using a Nikon
Eclipse 80i microscope with three axis motorized stage, video camera, Neurolucida interface
and Stereoinvestigator software (MicroBrightField Corp.). Cell counting was performed using
the 60x objective and cell size was determined using the Neurolucida Nucleator probe. All
counting and cell measurements were performed by a trained histologist, always blind to the
experimental condition. In every case, the same individual counted both the experimental and
control tissue. Only neurons with an identifiable nucleus were counted.
For quantification of Hcrt neurons in the light/dark phase, both hemispheres in every hypo-
thalamic section were stained and analyzed. In all other experimental groups, quantification
of Hcrt, HDC, ChAT and MCH neurons was performed bilaterally on every third section
throughout the hypothalamus, and the estimation of the total number of cells was obtained by
multiplying the results by the number of wells.
In the present study, we divided the hypothalamus into three different anatomical sectors
based on previously published work [26]. The perifornical area (PFA) was defined as the
region surrounding the fornix (within 140 mm of the perimeter of the structure). The rest of
the hypothalamus was further divided into a medial subdivision [medial hypothalamus
(MH)], which comprised the area from the medial limit of the fornix to the third ventricle
(3V), and a lateral subdivision [lateral hypothalamus (LH)], which extended from the medial
boundary of the fornix to the lateral edge of the hypothalamus (see Fig 1D insert).
Statistical analysis
Non-parametric statistics were used to compare differences among groups. Results were con-
sidered statistically significant if p<0.05.
Results
Hypocretin/Orexin
Animals that were sacrificed during the dark phase showed a significantly greater number
(24%) of Hcrt containing neurons compared to the animals sacrificed during the light phase,
(Table 2, Wilcoxon-Mann-Whitney, Z = 2.31, p = 0.02) (Fig 1A). There was no overlap in the
individual Hcrt cells counts between the animals in these two different experimental condi-
tions (Fig 1B). All Hcrt neurons were distributed within the hypothalamus as previously
described in mice [27] and there was no difference in the total number of hypothalamic sec-
tions that contained Hcrt cells (28.8 ± 0.4 and 30 ± 2 for the light and dark respectively). In
addition there was no difference in the extension of the Hcrt cell field in the medio-lateral axis
(973 ± 16 μm vs 1008 ± 16 μm for the light and dark respectively) as well as in the dorso-ven-
tral axis (620 ± 8 μm vs 649 ± 12 μm for the light and dark respectively) between conditions.
This data suggests that the extent of the Hcrt cell population remains unchanged at both time
points.
There was no significant difference in the overall soma size (106 ± 3 μm2 and 109 ± 1.4 μm2
for the light and dark respectively) (Fig 1C), and the anatomical parcellation of the hypothala-
mus (see Methods) did not indicate that the overall increase was restricted to any particular
subdivision (Fig 1D). Neuronal morphology appeared indistinguishable between conditions
(Fig 1E).
Fluctuation in the number of hypocretin/orexin and histamine producing neurons
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Fig 1. Hcrt neuronal number is increased in dark, but cell size and anatomical distribution are unchanged. (A) Average number of Hcrt cells in the
whole hypothalamus. (B) Total cell counts for each experimental subject. (C) Average size of Hcrt neurons. (D) Distribution of Hcrt neurons in different
hypothalamic subdivisions. (D) (insert), Diagram of one hypothalamic section of an experimental animal sacrificed during the light phase indicating the
anatomical subdivision used, circles represent Hcrt neurons (purple, medial hypothalamus; brown, lateral hypothalamus; blue, perifornical area). (E)
Photomicrographs of the same hypothalamic area of an animal sacrificed in the light phase (ZT5, top) and an animal sacrificed in the dark phase (ZT17,
bottom). Numbers indicate cell counts on slide. Inserts are higher (x40) magnification photomicrographs of the selected area (black square) for each
experimental condition. Calibration bar 250 μm and 10 μm respectively. Fx, fornix; LH, lateral hypothalamus; MH, medial hypothalamus; PFA, perifornical
area; 3V third ventricle. ** p = 0.02, Wilcoxon-Mann-Whitney, n = 4 for each group.
https://doi.org/10.1371/journal.pone.0178573.g001
Table 2. Number of neurons during the light and dark phase.
Light phase Dark phase
Hcrt 2,966 ± 84 3,668 ± 122 **
MCH 5,087 ± 165 4,966 ± 120
ChAt 961 ± 58 995 ± 35
HDC 907 ± 85 1215 ± 43 ++
All neuronal counts were determined using the same antibody, lot number and staining parameters.
** Hcrt Dark phase vs. Light phase, p = 0.02;
++ HDC Dark phase vs. Light phase, p = 0.02.
https://doi.org/10.1371/journal.pone.0178573.t002
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Histidine decarboxylase
As seen with the Hcrt cell group, the histaminergic neuronal population also showed a signifi-
cant increase (33.8%) in the number of neurons detected in animals sacrificed during the dark
phase compared to the light phase (Table 2, Wilcoxon-Mann-Whitney, Z = 2.31, p = 0.02) (Fig
2A). In addition, similar to what we observed in the in Hcrt population, there was no overlap
in the individual HDC+ cell counts between animals in these different experimental conditions
(Fig 2B). HDC neurons were located in the tuberomammillary nucleus as previously described
in mice [28]. There was no difference in the total number of hypothalamic sections that con-
tained HDC+ cells (8.3 ± 0.9 and 9.7 ± 0.6 for the light and dark respectively), and no signifi-
cant difference in the overall cell size (106 ± 6.7 μm2 and 102 ± 3.1 μm2 for the dark and light
respectively) (Fig 2C). Neuronal morphology appeared indistinguishable between experimen-
tal conditions.
Choline acetyltransferase
We did not observe a difference in the average number of ChAT+ neurons in the caudal sector
of the HDB extending from AP: 0.26 mm to 0.02 mm relative to bregma, a forebrain region in
which cholinergic cells are concentrated [29] (see below), between the animals sacrificed dur-
ing the dark and light phase (Fig 3A). In addition, we did not observe a difference in the cell
size (153 ± 3.5 μm2 and 146 ± 2.1 μm2 for the light and dark respectively) (Fig 3B) or in the
number of sections that contained cholinergic neurons (10 ± 0.9 and 10 ± 0.9 light and dark
respectively).
Melanin concentrating hormone
In contrast to what we observed in the Hcrt and histamine hypothalamic cell groups, there
was no significant difference in the average number of MCH neurons between the animals
Fig 2. HDC neuronal number is increased in dark, but cell size remains unchanged (like Hcrt cells). (A) Average
number of HDC cells in hypothalamic tuberomamillary region. ** p = 0.02, Wilcoxon-Mann-Whitney, n = 4 for each
group. (B) Total cell counts for each experimental subject. (C) Average size of HDC neurons.
https://doi.org/10.1371/journal.pone.0178573.g002
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sacrificed during the dark and light phase (Table 2) (Fig 4A). All MCH neurons were distrib-
uted within the hypothalamus as previously described in mice [30] and all anatomical subdivi-
sions showed comparable cell counts between experimental conditions (Fig 4B), indicating
that there is no shift in the distribution of these neurons between the two time points.
Fig 3. Number and size of ChAT neurons does not vary between the light and dark phase. (A) Average
number of ChAT cells in the horizontal diagonal band. n = 4 for each group. (B) Average size of ChAT
neurons.
https://doi.org/10.1371/journal.pone.0178573.g003
Fig 4. Number of MCH neurons remains unchanged, but cell size is increased in the light. (A) Average number of MCH cells in the light
and dark phases. (B) Distribution of MCH neurons in different hypothalamic subdivisions. (C) Average size of MCH neurons. ** p = 0.02,
Wilcoxon-Mann-Whitney, n = 4 for each group. LH, lateral hypothalamus; MH, medial hypothalamus; PFA, perifornical area
https://doi.org/10.1371/journal.pone.0178573.g004
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However, we observed a significant increase in the average soma size of MCH neurons during
the light phase compared to the dark phase (132.8 ± 2.3 μm2 and 115.6 ± 2.4 μm2 respectively,
Wilcoxon-Mann-Whitney, Z = 2.31, p = 0.02) (Fig 4C).
Colchicine treatment
The increase in the number of Hcrt cells during the dark phase suggested that during the light
phase the amount of Hcrt peptide in the cell bodies of a subgroup of Hcrt neurons was unde-
tectable to our antibody. Therefore we used colchicine, an inhibitor of microtubule polymeri-
zation, to accumulate the products of cellular synthesis in the cell body, thus increasing the
concentration of Hcrt in all Hcrt producing neurons. As expected, colchicine treated animals
showed a more robust Hcrt immunostaining, as illustrated in the photomicrograph in Fig 5A.
In addition, this procedure resulted in an increase in the number of Hcrt neurons detected
compared to the saline group (Table 3, Wilcoxon-Mann-Whitney, Z = 2.37, P = 0.02) (Fig 5B).
There was no overlap in the individual Hcrt cells counts between the animals in these two dif-
ferent experimental conditions (Fig 5C). To our surprise, the treatment revealed a significantly
greater number of Hcrt expressing neurons (17%), than the highest number seen under physi-
ological conditions during the dark phase (Table 3, Wilcoxon-Mann-Whitney, Z = 2.02,
p = 0.04) and an overall increase of 44% compared to the light phase condition. However,
there was no significant difference in the number of hypothalamic sections containing Hcrt
neurons in the colchicine treated animals compared to the dark phase group (35.2 ± 5.6 vs.
30 ± 2 for the colchicine treated and the dark phase respectively). This indicates that all Hcrt
expressing neurons detected after the colchicine treatment lay within the previously described
extent of the Hcrt neuronal field. The cell number increase was greatest in the medial sector
of the hypothalamus compared to the saline treated animals (Wilcoxon-Mann-Whitney,
Z = 2.56, p<0.05 with Bonferroni correction) (Fig 5D). Colchicine treatment did not signifi-
cantly affect the levels of preprohypocretin (PPHcrt) mRNA (PPHcrt mRNA) compared to
saline treated animals (Fig 5E).
In contrast to the situation with Hcrt cells, we did not find a significant increase in the
number of MCH cells detected after colchicine treatment, just as we did not see a diurnal dif-
ference (Table 3; Fig 5F). We observed a significant reduction in prepro melanin concentrating
hormone (PPMCH) mRNA levels (PPMCH mRNA) (Wilcoxon-Mann-Whitney, Z = 2.31,
p = 0.02) (Fig 5G) under the colchicine condition.
Colchicine did not affect the number of neurons expressing ChAT (Table 3; Fig 5H and 5I).
This is in agreement with previously published data indicating that colchicine has little effect
on products that are mainly located in the cell body such as the ChAT enzyme [31]. A similar
result would be expected in the histaminergic neuronal group since histaminergic neurons
were identified by the presence of HDC enzyme.
Discussion
Methodological considerations
The number of immunohistochemically-detected cells in animals with the same genetic back-
ground and age can vary as a function of tissue processing [32] [33], the antibody used [14]
[15], or the method of collecting data [34] [22]. To minimize experimental sources of variabil-
ity we processed all subjects’ brains using the same procedures, including antibody lot number.
Our work indicates that the level of production in a substantial portion of the Hcrt neurons
can fall below immunohistochemical detectability, with non-detection not necessarily an indi-
cation of the complete absence of Hcrt.
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An alternative method to visualize cells in tissue samples is the detection of specific mRNAs
by in situ hybridization (ISH). However, the presence of a particular mRNA in a cell does not
guarantee the expression of the encoded molecule. In addition, in narcoleptic patients for
example, ISH can fail to detect the appropriate PPHcrt mRNA [35] despite the presence of
Hcrt neurons (10%), confirmed by immunohistochemistry [36] [13] [37].
Fig 5. Colchicine further increases the number of Hcrt neurons. MCH and ChAT neuronal numbers remain unchanged. (A) Photomicrographs of the
same hypothalamic area of an animal treated with saline (top) or colchicine (bottom). Calibration bar 250 μm. Insert corresponds to a higher (x60)
magnification of the selected area (black square) of the animal that received colchicine. Black arrow indicates an Hcrt neuron. Calibration bar 10 μm. (B)
Total cell counts for each experimental subject. (C) Average number of Hcrt neurons in animals with ICV saline vs. ICV colchicine injections (** p = 0.02,
Wilcoxon-Mann-Whitney, n = 5 for each group). (D) Distribution of Hcrt neurons in the three different hypothalamic subdivisions regions. Increase is greatest
in the medial hypothalamic region (*p<0.05, Wilcoxon-Mann-Whitney with Bonferroni correction). (E) relative PPHcrt mRNA expression in the
hypothalamus. The difference is not significant. (F) Average number of MCH neurons in animals with ICV saline vs. ICV colchicine injections. (G) Relative
PPMCH mRNA expression in the hypothalamus (** p = 0.02, Wilcoxon-Mann-Whitney, n = 8 for each group). (H) Diagram of the basal forebrain of the
mouse depicting the anatomical localization of the cholinergic cell group analyzed. Lower, photomicrographs of the same basal forebrain area of an animal
treated with saline (above) or colchicine (below). In contrast to the increase in the staining of the Hcrt and MCH peptide, staining of ChAT is not increased by
colchicine treatment. Calibration bar, 250 μm. (I) Average number of ChAT neurons in animals with ICV saline vs. ICV colchicine injections. LH, lateral
hypothalamus; MH, medial hypothalamus; PFA, perifornical area; Fx, fornix; HDB, horizontal diagonal band; VP, ventral pallidum.
https://doi.org/10.1371/journal.pone.0178573.g005
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Diurnal rhythm
We report for the first time a significant increase in the number of detectable Hcrt and HDC
neurons during the dark phase. This data is compatible with the maximal activity reported
for these neuronal groups being during the active phase in rodents [38] [39] [40] [41] [6] [8].
However, it has previously been reported that there is no difference in the number of Hcrt
neurons detected by immunohistochemistry across the day-night cycle when assessed in labo-
ratory rodents [40] [42] [43] [44]. There are several explanations for this discrepancy. Martinez
et al [42] used just one hemi section per animal for the analysis. The low sampling size would
have reduced the statistical power of the results reported. In our study we analyzed every hypo-
thalamic section containing Hcrt immunopositive neurons, quantifying the cell number in
both hemispheres for each experimental subject. Estabrooke et al [40], in addition to using a
lower sampling size (3 sections per animal), reports that the “. . .the number of orexin neu-
rons. . .varied by as much as a factor of two between animals. . .”. Using the complete counting
technique we see a maximum within group variation between subjects of 11.6 to 17.6%. Mar-
ston et al [44] conducted their experiments in constant light conditions, and light intensity has
been shown to significantly affect the number of neurons expressing Hcrt [45]. Other factors
such as species difference [43] might also have contributed to this difference.
The increase in the number of identified Hcrt neurons during the dark phase indicates that
a subpopulation of cells augments their Hcrt peptide content at this time point, thus becoming
immunohistochemically detectable. This is in accordance with previously published data indi-
cating the highest levels of the Hcrt-1 peptide in the LH, as measured by microdialysis, occurs
during the dark phase [46] and may reflect an increase in the synthesis as well as a shift in the
anabolism/catabolism of the peptides. The concentration of Hcrt-1 in the pontine region also
peaks during the dark phase (ZT18) [47], indicating a higher rate of Hcrt transport to extra
hypothalamic targets since, to our knowledge, there are no reports demonstrating Hcrt synthe-
sis in the terminals.
In one scenario, the “non-visible Hcrt cells” belong to a functionally specific subpopulation
of Hcrt neurons that increase their Hcrt synthesis only during the dark phase. Alternatively,
Hcrt neurons can be “randomly” put "off line" from peptide production during the light phase.
Physiological capabilities would be maintained during each phase, but a different population
of neurons would be active in light and dark phases.
Analogous to what we observed for the Hcrt system, the increase in the number of hista-
minergic neurons detected in the dark phase indicates a higher concentration of HDC enzyme
within these cells. This could be the result of an augmented synthesis of the enzyme, since the
mRNA HDC levels peak during the dark phase [48]. However, other factors like a slower rate
of transportation to the terminals, an increased stability of the enzyme or alterations in the rate
of degradation may also affect the concentration of the enzyme in the cell body.
Table 3. Number of neurons after colchicine treatment.
Saline ICV Colchicine ICV
Hcrt 3,381 ± 319 4,282 ± 332 ##, $ $,
MCH 4,871 ± 62 4,936 ± 61
ChAt 1,104 ± 15 1,069 ± 15
All neuronal counts were determined using the same antibody, lot number and staining parameters.
## Hcrt Colchicine ICV vs. Saline ICV, p = 0.02;
$ $ Hcrt Colchicine ICV vs. Dark phase, p = 0.04.
https://doi.org/10.1371/journal.pone.0178573.t003
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The increase in the enzyme content may be partly responsible for the increased levels of
this neurotransmitter reported during the dark phase in the anterior and posterior hypothala-
mus [38] [49]. We cannot determine if the number of HDC cells observed during the dark
phase represents the maximum number of histamine neurons, or if there are still more cells
that cannot be detected with our immunohistochemical technique. We have previously
reported that human narcoleptic patients have a 64% increase in the number of HDC neurons,
with an even greater increase reported at the same time by another group [15]. It remains to be
determined if a large number of cells capable of producing HDC is present in non-pathological
humans and increases their synthesis of HDC as part of the development of narcolepsy, or
whether the disease causes a new group of cells to produce HDC.
In contrast with the Hcrt and histamine system, we did not detect a difference in the num-
ber of neurons expressing ChAT or MCH at the two time points analyzed, thus the day-night
differential is not a universal feature of signaling systems. We observed a significant increase
in the average size of the MCH cells during the light phase compared to the dark phase. To our
surprise, colchicine treatment did not affect the numbers of MCH neurons. It is possible that
MCH neurons have a constantly higher concentration of peptide or the antibody against
MCH is more sensitive, therefore all neurons expressing MCH are detected. However we
observed a significant decrease in the PPMCH mRNA, possibly the result of a negative feed-
back loop mechanism elicited by the blockade of transportation of the MCH peptide outside
of the cell body.
Fluctuation in Hcrt cell numbers
A recent study has reported an increase in the number of Hcrt neurons (~20%) following cor-
ticosterone treatment [34], indicating that Hcrt production can be increased or induced in
a subset of neurons by this steroid. The authors do not make any claims as to the nature of
these neurons, thus we speculate that the treatment increases the production of peptides in the
"non-visible” population of Hcrt neurons seen under our conditions.
The results of the current study show a naturally occurring increase in the number of Hcrt
expressing neurons during the dark phase. However, after blocking microtubule transport we
observed an additional 17% increase in the cell counts compared to the highest physiological
value we observed (in the dark condition), bringing the number to 44% above the level
recorded in the light phase. We cannot rule out the possibility that there is an even greater
number of cells capable of producing Hcrt and that the 52 hours of colchicine treatment is not
enough to accumulate sufficient peptide to make the cell bodies detectable. However, main-
taining the viability of the animals beyond 52 hours is challenging.
We have previously reported that human narcolepsy is characterized by an average loss of
90% of Hcrt neurons. Narcolepsy with cataplexy has not been reported in humans having 15%
or more of the average number of Hcrt cells in controls [13] [50]. These results suggest that if
it were possible to increase the number of Hcrt cells in human narcoleptics by the17% per-
centage visible with colchicine treatment, it might be possible to attenuate or reverse narco-
lepsy with cataplexy. The development of techniques to achieve this and similar changes in
other neuronal systems could have a major impact on the treatment of neurological disease.
Final conclusions
Our study presents evidence that there is a significant fluctuation in the number of detected
Hcrt and HDC neurons under physiological conditions. We also show that the total number
of potential Hcrt expressing cells is considerably greater than previously thought. Based on the
physiological variation and the even greater number of detectable Hcrt neurons seen after
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colchicine administration, we suggest that these systems may increase or decrease their num-
bers depending on particular behaviors that accompany the animals’ active phase. Therefore it
is not just the activity of the neurons, but the numbers too, implying that target regions inner-
vated by certain neuronal subgroups may receive innervation of a particular transmitter only
under specific conditions. These phenomena reveal a new complexity in the dynamics of dif-
ferent identifiable cell groups.
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